Intra-Cellular Therapies Inc. (23I)
Market Open
1 Apr, 20:00
XSTU €
122. 00
+1
+0.83%
€
- Market Cap
- P/E Ratio
- Div Yield
0 Volume
- Eps
€ 121
Previous Close Day Range
120 122
Year Range
59 125
Earnings results expected in 63 days
Summary
23I trading today higher at €122, an increase of 0.83% from yesterday's close, completing a monthly increase of 1.67% or €2. Over the past 12 months, 23I stock gained 52.5%.
23I is not paying dividends to its shareholders.
The last earnings report, released on May 05, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports. The next scheduled earnings report is due on Aug 05, 2025.
The stock of the company had never split.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on XSTU (EUR).
Want to track 23I and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
23I Chart
No Data
Intra-Cellular Therapies Inc. (23I) FAQ
What is the stock price today?
The current price is €122.00.
On which exchange is it traded?
Intra-Cellular Therapies Inc. is listed on XSTU.
What is its stock symbol?
The ticker symbol is 23I.
Does it pay dividends? What is the current yield?
It does not pay dividends to its shareholders.
What is its market cap?
As of today, no market cap data is available.
What is the earnings per share?
The EPS is 0.
When is the next earnings date?
The next earnings report will release on Aug 05, 2025.
Has Intra-Cellular Therapies Inc. ever had a stock split?
No, there has never been a stock split.
2025 © Marketlog. All Rights Reserved.
